Drugmaker Partners Launch Copycat for Arthritis Drug Humira
Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie’s blockbuster arthritis drug Humira.
Stay updated with breaking news from Cigna Group Cin Express Scripts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie’s blockbuster arthritis drug Humira.
Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie's blockbuster arthritis drug Humira, while another drugmaker entered...
Multiple copycats announced to rival AbbVie-owned blockbuster arthritis drug
By Patrick Wingrove (Reuters) - Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version ...